| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |